ICG:LSEICG plc Analysis
Data as of 2026-07-17 - not real-time
£1,890.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
ICG plc is trading well below its 20‑day SMA of 1758 and the 200‑day SMA of 1854, confirming a bearish price direction despite a bullish MACD signal and a relatively strong RSI of 64. The stock’s trailing P/E of 11.5 is markedly lower than the asset‑management industry average of 17.9, while the DCF‑derived fair value of ~£2,730 suggests roughly 30% upside potential. A dividend yield of 4.56% with a payout ratio near 51% is supported by a robust cash position that exceeds total debt, and the beta of 0.83 points to lower market‑wide volatility. Valuation appears attractive and the dividend framework looks sustainable, even as revenue has contracted by about 22% year‑on‑year.
However, the 30‑day volatility of nearly 32% and a clear bearish trend flag short‑term downside risk. The company’s diversified geographic exposure and focus on senior‑secured private debt mitigate sector‑specific headwinds, while regulatory scrutiny typical for UK financial services remains moderate. Overall, the fundamentals and valuation metrics support a longer‑run bullish case, but traders should respect the near‑term price weakness.
However, the 30‑day volatility of nearly 32% and a clear bearish trend flag short‑term downside risk. The company’s diversified geographic exposure and focus on senior‑secured private debt mitigate sector‑specific headwinds, while regulatory scrutiny typical for UK financial services remains moderate. Overall, the fundamentals and valuation metrics support a longer‑run bullish case, but traders should respect the near‑term price weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical trend despite bullish MACD
- High short‑term volatility
- Attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 30% upside to DCF fair value
- Undervalued relative to industry P/E
- Sustainable dividend and strong cash position
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Diversified global asset base
- Low beta indicating defensive characteristics
- Consistent earnings margin and dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-21.80%
Profit Margin48.94%
P/E Ratio11.5
ROE18.44%
ROA4.97%
Debt/Equity46.98
P/B Ratio2.0
Op. Cash Flow£846.1M
Industry P/E17.9
Technical Analysis
TrendBearish
RSI64.4
Support£1,604.00
Resistance£1,937.00
MA 20£1,758.10
MA 50£1,799.36
MA 200£1,853.74
MACDBullish
VolumeStable
Fear & Greed Index89
Valuation
Fair Value£2,730.21
Target Price£2,474.00
Upside/Downside30.90%
GradeUndervalued
TypeValue
Dividend Yield4.56%
Risk Assessment
Beta0.83
Volatility31.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.